Literature DB >> 32538284

A meta-analysis of remote ischaemic conditioning in experimental stroke.

Philippa Weir1, Ryan Maguire1, Saoirse E O'Sullivan1, Timothy J England1,2.   

Abstract

Remote ischaemic conditioning (RIC) is achieved by repeated transient ischaemia of a distant organ/limb and is neuroprotective in experimental ischaemic stroke. However, the optimal time and methods of administration are unclear. Systematic review identified relevant preclinical studies; two authors independently extracted data on infarct volume, neurological deficit, RIC method (administration time, site, cycle number, length of limb occlusion (dose)), species and quality. Data were analysed using random effects models; results expressed as standardised mean difference (SMD). In 57 publications incorporating 99 experiments (1406 rats, 101 mice, 14 monkeys), RIC reduced lesion volume in transient (SMD -2.0; 95% CI -2.38, -1.61; p < 0.00001) and permanent (SMD -1.54; 95% CI -2.38, -1.61; p < 0.00001) focal models of ischaemia and improved neurological deficit (SMD -1.63; 95% CI -1.97, -1.29, p < 0.00001). In meta-regression, cycle length and number, dose and limb number did not interact with infarct volume, although country and physiological monitoring during anaesthesia did. In all studies, RIC was ineffective if the dose was <10 or ≥50 min. Median study quality was 7 (range 4-9/10); Egger's test suggested publication bias (p < 0.001). RIC is most effective in experimental stroke using a dose between 10 and 45 min. Further studies using repeated dosing in animals with co-morbidities are warranted.

Entities:  

Keywords:  Ischemic stroke; meta-analysis; pre-clinical; remote ischemic conditioning; stroke

Mesh:

Year:  2020        PMID: 32538284      PMCID: PMC7747156          DOI: 10.1177/0271678X20924077

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  44 in total

1.  RECAST (Remote Ischemic Conditioning After Stroke Trial): A Pilot Randomized Placebo Controlled Phase II Trial in Acute Ischemic Stroke.

Authors:  Timothy J England; Amanda Hedstrom; Saoirse O'Sullivan; Richard Donnelly; David A Barrett; Sarir Sarmad; Nikola Sprigg; Philip M Bath
Journal:  Stroke       Date:  2017-03-06       Impact factor: 7.914

2.  Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach.

Authors:  Nicolas A Crossley; Emily Sena; Jos Goehler; Jannekke Horn; Bart van der Worp; Philip M W Bath; Malcolm Macleod; Ulrich Dirnagl
Journal:  Stroke       Date:  2008-01-31       Impact factor: 7.914

3.  The role of p38MAPK signal pathway in the neuroprotective mechanism of limb postconditioning against rat cerebral ischemia/reperfusion injury.

Authors:  Hao Li; Suxian Zhou; Lan Wu; Kaixiang Liu; Yuhu Zhang; Guixian Ma; Lijuan Wang
Journal:  J Neurol Sci       Date:  2015-08-05       Impact factor: 3.181

4.  Timing of recanalization after intravenous thrombolysis and functional outcomes after acute ischemic stroke.

Authors:  Leonard L L Yeo; Prakash Paliwal; Hock L Teoh; Raymond C Seet; Bernard P L Chan; Shen Liang; Narayanaswamy Venketasubramanian; Rahul Rathakrishnan; Aftab Ahmad; Kay W P Ng; Pei K Loh; Jonathan J Y Ong; Benjamin R Wakerley; Vincent F Chong; Girish Bathla; Vijay K Sharma
Journal:  JAMA Neurol       Date:  2013-03-01       Impact factor: 18.302

5.  Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke.

Authors:  Md Nasrul Hoda; Shahneela Siddiqui; Samuel Herberg; Sudharsan Periyasamy-Thandavan; Kanchan Bhatia; Sherif S Hafez; Maribeth H Johnson; William D Hill; Adviye Ergul; Susan C Fagan; David C Hess
Journal:  Stroke       Date:  2012-08-21       Impact factor: 7.914

Review 6.  Remote ischaemic conditioning-a new paradigm of self-protection in the brain.

Authors:  David C Hess; Rolf A Blauenfeldt; Grethe Andersen; Kristina D Hougaard; Md Nasrul Hoda; Yuchuan Ding; Xunming Ji
Journal:  Nat Rev Neurol       Date:  2015-11-20       Impact factor: 42.937

7.  Ischemic Conditioning Is Safe and Effective for Octo- and Nonagenarians in Stroke Prevention and Treatment.

Authors:  Ran Meng; Yuchuan Ding; Karam Asmaro; David Brogan; Lu Meng; Meng Sui; Jingfei Shi; Yunxia Duan; Zhishan Sun; Yang Yu; Jianping Jia; Xunming Ji
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

8.  The mitochondria-targeted antioxidants and remote kidney preconditioning ameliorate brain damage through kidney-to-brain cross-talk.

Authors:  Denis N Silachev; Nikolay K Isaev; Irina B Pevzner; Ljubava D Zorova; Elena V Stelmashook; Svetlana V Novikova; Egor Y Plotnikov; Vladimir P Skulachev; Dmitry B Zorov
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

9.  Endothelial cell-derived exosomes protect SH-SY5Y nerve cells against ischemia/reperfusion injury.

Authors:  Bing Xiao; Yi Chai; Shigang Lv; Minhua Ye; Miaojing Wu; Liyuan Xie; Yanghua Fan; Xingen Zhu; Ziyun Gao
Journal:  Int J Mol Med       Date:  2017-08-23       Impact factor: 4.101

10.  SYRCLE's risk of bias tool for animal studies.

Authors:  Carlijn R Hooijmans; Maroeska M Rovers; Rob B M de Vries; Marlies Leenaars; Merel Ritskes-Hoitinga; Miranda W Langendam
Journal:  BMC Med Res Methodol       Date:  2014-03-26       Impact factor: 4.615

View more
  6 in total

Review 1.  Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular Workshop.

Authors:  R M Bell; M Basalay; H E Bøtker; S Beikoghli Kalkhoran; R D Carr; J Cunningham; S M Davidson; T J England; S Giesz; A K Ghosh; P Golforoush; A V Gourine; D J Hausenloy; G Heusch; B Ibanez; P Kleinbongard; S Lecour; K Lukhna; M Ntsekhe; M Ovize; A D Salama; G Vilahur; J M Walker; D M Yellon
Journal:  Basic Res Cardiol       Date:  2022-08-15       Impact factor: 12.416

2.  Effect of Remote Ischemic Conditioning vs Usual Care on Neurologic Function in Patients With Acute Moderate Ischemic Stroke: The RICAMIS Randomized Clinical Trial.

Authors:  Hui-Sheng Chen; Yu Cui; Xiao-Qiu Li; Xin-Hong Wang; Yu-Tong Ma; Yong Zhao; Jing Han; Chang-Qing Deng; Mei Hong; Ying Bao; Li-Hong Zhao; Ting-Guang Yan; Ren-Lin Zou; Hui Wang; Zhuo Li; Li-Shu Wan; Li Zhang; Lian-Qiang Wang; Li-Yan Guo; Ming-Nan Li; Dong-Qing Wang; Qiang Zhang; Da-Wei Chang; Hong-Li Zhang; Jing Sun; Chong Meng; Zai-Hui Zhang; Li-Ying Shen; Li Ma; Gui-Chun Wang; Run-Hui Li; Ling Zhang; Cheng Bi; Li-Yun Wang; Duo-Lao Wang
Journal:  JAMA       Date:  2022-08-16       Impact factor: 157.335

3.  Neuroprotection by remote ischemic conditioning in the setting of acute ischemic stroke: a preclinical two-centre study.

Authors:  Maryna V Basalay; Marlene Wiart; Fabien Chauveau; Chloe Dumot; Christelle Leon; Camille Amaz; Radu Bolbos; Diana Cash; Eugene Kim; Laura Mechtouff; Tae-Hee Cho; Norbert Nighoghossian; Sean M Davidson; Michel Ovize; Derek M Yellon
Journal:  Sci Rep       Date:  2020-10-09       Impact factor: 4.379

4.  Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke.

Authors:  Shereen Nizari; Marina Basalay; Philippa Chapman; Nils Korte; Alla Korsak; Isabel N Christie; Shefeeq M Theparambil; Sean M Davidson; Frank Reimann; Stefan Trapp; Derek M Yellon; Alexander V Gourine
Journal:  Basic Res Cardiol       Date:  2021-05-03       Impact factor: 17.165

5.  Preclinical evidence of remote ischemic conditioning in ischemic stroke, a metanalysis update.

Authors:  Coral Torres-Querol; Manuel Quintana-Luque; Gloria Arque; Francisco Purroy
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

Review 6.  Determination of significant parameters in remote ischemic postconditioning for ischemic stroke in experimental models: A systematic review and meta-analysis study.

Authors:  Kezhou Liu; Zhengting Cai; Quanwei Zhang; Jiatong He; Yinuo Cheng; Shaonong Wei; Mengjie Yin
Journal:  CNS Neurosci Ther       Date:  2022-07-27       Impact factor: 7.035

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.